Page 4 - Affinity Asset Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affinity asset advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affinity Asset Advisors Today - Breaking & Trending Today

BeiGene, Ltd. (NASDAQ:BGNE) Receives $251.93 Average Price Target from Brokerages

Shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month […] ....

United States , Sanfordc Bernstein , Julia Aijun Wang , John Oyler , Jpmorgan Chase Co , Beigene Ltd , Pricet Rowe Associates Inc , Capital International Sarl , Securities Exchange Commission , Capital International Ltd , Affinity Asset Advisors , Capital International Inc , Get Free Report , Exchange Commission , Haijun Wang , Asset Advisors , International Sarl , Capital International , Get Free , Beigene Daily ,

Q32 Bio (NASDAQ:QTTB) Earns Outperform Rating from Analysts at SVB Leerink

Research analysts at SVB Leerink initiated coverage on shares of Q32 Bio (NASDAQ:QTTB – Get Free Report) in a note issued to investors on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating and a $54.00 price target on the stock. SVB Leerink’s price objective would indicate a potential upside of 78.81% from the company’s […] ....

Piper Sandler , Capital Management , Bio Inc , Vanguard Group Inc , Acadian Asset Management , Affinity Asset Advisors , Ikarian Capital , Get Free Report , Stock Down , Asset Management , Asset Advisors , Vanguard Group ,

Rezolute's (RZLT) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Rezolute (NASDAQ:RZLT – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $14.00 price target on the stock. A number of other analysts have also recently weighed in on the stock. JMP Securities reissued a market outperform rating and set […] ....

United States , Myoung Jin Kim , Daron Evans , Vivo Capital , Vanguard Group Inc , Rezolute Inc , Affinity Asset Advisors , Maxim Group , Acadian Asset Management , Rosalind Advisors Inc , Securities Exchange Commission , Free Report , Exchange Commission , Director Young Jin Kim , Asset Advisors , Asset Management , Get Free Report , Rezolute Daily ,

Brokerages Set Cullinan Oncology, Inc. (NASDAQ:CGEM) Price Target at $31.00

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […] ....

United States , Jennifer Michaelson , Stifel Nicolaus , William Blair , Parkman Healthcare Partners , Securities Exchange Commission , Cullinan Oncology Inc , Affinity Asset Advisors , Franklin Resources Inc , Cullinan Oncology , Get Free Report , Exchange Commission , Asset Advisors , Healthcare Partners , Trexquant Investment , Oncology Stock Down , Get Free , Cullinan Oncology Daily ,

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Neutral" Rating from HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $5.50 target price on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q2 2024 earnings at ($0.33) EPS, FY2024 earnings at […] ....

Affinity Asset Advisors , Insider Transactions At Terns Pharmaceuticals , Terns Pharmaceuticals Stock Performance , Analyst Recommendations For Terns Pharmaceuticals , Janus Henderson Group , Vivo Opportunity Llc , Terns Pharmaceuticals , News Ratings For Terns Pharmaceuticals Daily , Walleye Trading , Pricet Rowe Associates Inc , Institutional Investors Weigh In On Terns Pharmaceuticals , Terns Pharmaceuticals Company Profile , Kennedy Capital Management , Terns Pharmaceuticals Inc , Free Report , Moderate Buy , Get Free Report , Vivo Opportunity , Henderson Group , Capital Management , Asset Advisors , Terns Pharmaceuticals Daily ,